Asosiy kontentga oʻtish
Maqola

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Shilong YangYan LiInstitute of MicrobiologyLianpan DaiCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaJianfeng WangNational Institute for Food and Drug Control, Beijing, ChinaPeng HeNational Institute for Food and Drug Control, Beijing, ChinaChanggui LiNational Institute for Food and Drug Control, Beijing, ChinaXin FangNational Institute for Food and Drug Control, Beijing, ChinaChenfei WangNational Institute for Food and Drug Control, Beijing, ChinaXiang ZhaoNational Institute for Food and Drug Control, Beijing, ChinaEnqi HuangChangwei W. WuZaixin ZhongFengze WangCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaXiaomin DuanCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaSiyu TianInstitute of MicrobiologyLili WuCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaYan LiuYi LuoZhihai ChenCenter of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, ChinaFangjun LiHunan Provincial Center for Disease Control and Prevention, Changsha, ChinaJunhua LiHunan Provincial Center for Disease Control and Prevention, Changsha, ChinaXian YuChongqing Medical UniversityHong RenChongqing Medical UniversityLihong LiuBeijing Chao-Yang Hospital, Capital Medical University, Beijing, ChinaShufang MengNational Institute for Food and Drug Control, Beijing, ChinaJinghua YanInstitute of MicrobiologyZhongyu HuNational Institute for Food and Drug Control, Beijing, ChinaLidong GaoHunan Provincial Center for Disease Control and Prevention, Changsha, China. Electronic address: [email protected]George F. GaoCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
2021en
ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

Iqtiboslar va manbalar

6 ta iqtibos0 ta foydalanilgan manba